logo-loader

IGF Oncology

Receive alerts
Market:
PRIVATE
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

IGF Oncology is a biotech company developing targeted anti-cancer drugs with better efficacy and lower side effects compared to existing chemotherapy treatments. Our lead drug, IGF-MTX, targets the deadly blood cancer MDS, and is currently in clinical trials at the Mayo Clinic, and the results so far are very promising.